300406.SZ SHZ
Beijing Strong Biotechnologies, Inc.
1W: +1.3%
1M: +3.2%
3M: +6.5%
YTD: -10.4%
1Y: -17.1%
3Y: -39.8%
5Y: -29.5%
¥11.94 ($1.78)
+0.17 (+1.44%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Balance Sheet Trends
Total Assets
$5.6B
+7.7% ▲
5Y CAGR: +20.9%
Total Liabilities
$1.4B
-0.8% ▼
5Y CAGR: +51.1%
Shareholders Equity
$4.1B
+11.1% ▲
5Y CAGR: +16.0%
Cash & Investments
$1.0B
+44.0% ▲
5Y CAGR: +35.8%
Total Debt
$1.1B
-0.2% ▼
5Y CAGR: +65.9%
Net Debt
$86M
-78.8% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $577M | $383M | $341M | $724M | $1.0B |
| Short-Term Investments | $5M | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $582M | $383M | $341M | $724M | $1.0B |
| Net Receivables | $785M | $961M | $1.0B | $1.1B | $1.1B |
| Inventory | $247M | $252M | $220M | $230M | $221M |
| Other Current Assets | $152M | $147M | $413M | $208M | $149M |
| Total Current Assets | $1.8B | $1.7B | $2.1B | $2.3B | $2.6B |
| Property, Plant & Equip. | $324M | $366M | $439M | $555M | $582M |
| Goodwill & Intangibles | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B |
| Long-Term Investments | $25M | $66M | $48M | $0 | $0 |
| Other Non-Current Assets | $78M | $368M | $283M | $507M | $634M |
| Total Non-Current Assets | $2.2B | $2.6B | $2.5B | $2.8B | $3.0B |
| Total Assets | $4.0B | $4.3B | $4.6B | $5.2B | $5.6B |
| — Liabilities — | |||||
| Accounts Payable | $42M | $47M | $38M | $82M | $69M |
| Short-Term Debt | $38M | $163M | $81M | $0 | $106K |
| Deferred Revenue | $158M | $195M | $167M | $19M | $0 |
| Other Current Liabilities | $141M | $202M | $12M | $105M | $67M |
| Total Current Liabilities | $243M | $608M | $298M | $297M | $278M |
| Long-Term Debt | $262M | $766M | $1.0B | $1.1B | $1.1B |
| Other Non-Current Liab. | -$2M | $0 | $0 | $17M | $0 |
| Total Non-Current Liabilities | $298M | $799M | $1.0B | $1.2B | $1.2B |
| Total Liabilities | $540M | $1.4B | $1.3B | $1.5B | $1.4B |
| — Equity — | |||||
| Common Stock | $589M | $589M | $589M | $588M | $588M |
| Retained Earnings | $1.3B | $1.6B | $2.0B | $2.4B | $2.8B |
| Accumulated OCI | $209M | $264M | $439M | $177M | $472M |
| Total Stockholders Equity | $3.2B | $2.9B | $3.3B | $3.7B | $4.1B |
| Total Liabilities & Equity | $4.0B | $4.3B | $4.6B | $5.2B | $5.6B |
| — Key Metrics — | |||||
| Total Debt | $300M | $1.1B | $1.1B | $1.1B | $1.1B |
| Net Debt | -$277M | $742M | $762M | $408M | $86M |
| Total Investments | $30M | $66M | $48M | $0 | $0 |